| RAS | Resistance-associated substitution |
| DAA | Direct-acting antiviral |
| SMV/PEG-IFN/RBV | Simeprevir/pegylated-interferon/ribavirin |
| DCV/ASV | Daclatasvir/asunaprevir |
| CHC | Chronic hepatitis C |
| HCV | Hepatitis C virus |
| HCC | Hepatocellular carcinoma |
| SVR | Sustained viral response |